6.94
Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten
What analysts say about Day One Biopharmaceuticals Inc. stockConsistently high yield - Autocar Professional
Day One Biopharmaceuticals Inc. Stock Analysis and ForecastBreakthrough profit margins - jammulinksnews.com
What makes Day One Biopharmaceuticals Inc. stock price move sharplyConsistent High Return Strategy - Newser
Is Day One Biopharmaceuticals Inc. a good long term investmentSkyrocketing profit margins - jammulinksnews.com
What drives Day One Biopharmaceuticals Inc. stock priceFree Daily Trading Room Entry - jammulinksnews.com
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025 - GlobeNewswire
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Teacher Retirement System of Texas - Defense World
How Day One Biopharmaceuticals Inc. stock performs during market volatilityFree Access to Community - Newser
Why Day One Biopharmaceuticals Inc. stock attracts strong analyst attentionTop Performing Low Risk Stocks - Newser
When the Price of (DAWN) Talks, People Listen - news.stocktradersdaily.com
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Recommendation of “Buy” by Brokerages - Defense World
Wealth Enhancement Advisory Services LLC Makes New $88,000 Investment in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Announces Pricing of Upsized Initial Public Offering - IT Business Net
Day One Biopharmaceuticals, Inc. shares rise 4.16% intraday after positive mid-term outlook from Lonza Group. - AInvest
DAY ONE BIOPHARMACEUTICALS Earnings Preview: Recent $DAWN Insider Trading, Hedge Fund Activity, and More - Nasdaq
AMPY Stock: A Voyage Through Amplify Energy Corp’s Finances - investchronicle.com
(DAWN) On The My Stocks Page - news.stocktradersdaily.com
When Will Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Breakeven? - Yahoo Finance
TimesSquare Capital U.S. Small Cap Growth Strategy Exited its Position in Day One Biopharmaceuticals Inc. (DAWN) - MSN
Is Day One Biopharmaceuticals, Inc. overvalued or undervalued? - MarketsMojo
Day 9 of Loss Streak for Day One Biopharmaceuticals Stock with -12% Return (vs. -50% YTD) [6/20/2025] - Trefis
Day 8 of Loss Streak for Day One Biopharmaceuticals Stock with -11% Return (vs. -49% YTD) [6/18/2025] - Trefis
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of “Buy” by Brokerages - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):